Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on March 17th, 2023%
A new study validates standard electronic instrument measures of healthy individuals and people with schizophrenia to enable reliable clinical trials for treating the disease. . . . → Read More: Standard Electronic Biomarkers Validated for Schizophrenia
By Alan, on March 5th, 2023%
As three vaccines against respiratory syncytial virus reach FDA review, a scientific conference explored a key breakthrough researchers achieved to get to this point. . . . → Read More: RSV Vaccine Breakthrough Examined at AAAS Meeting
By Alan, on March 3rd, 2023%
A panel of data scientists at a professional meeting says artificial intelligence needs more rigorous oversight, but many questions remain on who and how to do the regulating. . . . → Read More: Panel: A.I. Regulation Needed, But Long Way Off
By Alan, on January 13th, 2023%
A new company developing diagnostics for neurological and other disorders based on environmental exposures is raising $16 million in venture funds. . . . → Read More: Environmental Biomarker Start-Up Gains $16M in Early Funds
By Alan, on January 11th, 2023%
A new company developing techniques to analyze internal physiological sounds captured by stethoscopes as health indicators is raising $3.7 million in seed funds. . . . → Read More: Audio Digital Biomarkers Start-Up Raises $3.7M in Seed Funds
By Alan, on December 28th, 2022%
The opioid overdose drug naloxone in nasal spray form is receiving priority review from the Food and Drug Administration as an over-the-counter drug. . . . → Read More: Over-the-Counter Naloxone Receiving Faster FDA Review
By Alan, on December 6th, 2022%
The Food and Drug Administration authorized for marketing an algorithm-driven medical device for diagnosing a common, but difficult to detect, type of heart failure. . . . → Read More: FDA Clears AI Heart Failure Detection System
By Alan, on December 2nd, 2022%
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays. . . . → Read More: Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
By Alan, on November 2nd, 2022%
A vaccine designed from engineered live viruses and taken as nose drops to prevent respiratory syncytial virus received a Food and Drug Administration fast-track designation. . . . → Read More: RSV Nose Drops Vaccine Gets FDA Fast Track Tag
By Alan, on October 24th, 2022%
A California state research agency is funding preclinical development of a gel designed to regenerate stem cells in the skin to help heal venous skin ulcers. . . . → Read More: Grant Funds Regenerative Gel for Treating Skin Ulcers
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|